Skip to main content
Paul Schacknow, MD, Ophthalmology, Stuart, FL

Paul N. Schacknow MD PhD

Glaucoma Related


Consultant in Glaucoma East Florida Eye Institute

Join to view full profile
  • 509 SE Riverside DrSte 302Stuart, FL 34994

  • Phone+1 772-287-9000

  • Fax+1 772-287-0507

Dr. Schacknow is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Paul Schacknow is an ophthalmologist based in Stuart, FL, specializing in glaucoma and related conditions. He completed his medical education at the University of Miami Leonard M. Miller School of Medicine and further specialized through a residency at Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical School, followed by a fellowship at Sutter Health/California Pacific Medical Center. Dr. Schacknow has been serving as a Clinical Full Professor at Nova Southeastern since 2003. His professional interests include cataract surgery and glaucoma drainage implant surgery. He has authored publications on glaucoma management, including "Clinical Glaucoma Care: The Essentials." His contributions have been recognized with awards from the American Academy of Ophthalmology and other notable organizations.

Education & Training

  • Sutter Health/California Pacific Medical Center
    Sutter Health/California Pacific Medical CenterFellowship, Ophthalmology, 1987 - 1988
  • Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical School
    Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 1984 - 1987
  • MetroWest Medical Center
    MetroWest Medical CenterInternship, Transitional Year, 1983 - 1984
  • University of Miami Leonard M. Miller School of Medicine
    University of Miami Leonard M. Miller School of MedicineClass of 1983
  • City University of New York
    City University of New YorkPh.D., Experimental Psychology, 1970 - 1976

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1989 - 2028
  • CA State Medical License
    CA State Medical License 1987 - 2020
  • MA State Medical License
    MA State Medical License 1983 - 2009
  • AL State Medical License
    AL State Medical License 1988 - 2001
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • LEO Continuing Education Recognition Award American Academy of Ophthalmology, 2007
  • Who's Who in Medicine and Healthcare - 6th Edition 2006
  • Achievement Award American Academy of Ophthalmology, 2005

Publications & Presentations

PubMed

Journal Articles

  • Association Between Intraocular Pressure Variation and Glaucoma Progression: Data from a United States Chart Review  
    Lee, PP et al. and the Glaucoma Care Study Group (including Schacknow, PN), American Journal of Ophthalmology, 1/1/2007
  • Travoprost 0004% With And Without Benzalkonium Chloride: A Comparison Of Safety And Efficacy  
    Lewis, RA et al. and the Travoprost BAC-free Study Group (including Schacknow, PN), J of Glaucoma, 1/1/2007
  • The Safety And Intraocular Pressure-Lowering Efficacy Of Brimonidine Tartrate 015% Preserved With Polyquaternium-1  
    Whitson, J and the Brimonidine 0.15% Study Group (including Schacknow, PN), Ophthalmology, 1/1/2006

Books/Book Chapters

Abstracts/Posters

  • A Comparison of Travoprost 0.004% / Timolol 0.5% Ophthalmic Solution And The Concomitant Administration Of Travatan And Timolol 0.5%
    Hughes, BA, et al, and the Travoprost 0.004% / Timolol 0.5% Study Group (including Schacknow, PN), Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, 1/28/2004
  • Three Month Comparison Of The Safety And Efficacy Of Travoprost 0.004% / Timolol 0.5% Ophthalmic Solution To Travatan And Timolol 0.5%
    Barnebey, HS, et al. and the Travoprost 0.004% / Timolol 0.5% Study Group (including Schacknow, PN), Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, 1/26/2004
  • An Analysis Of The Intraocular Pressure Lowering Efficacy Of Travoprost In Patients On Multiple Therapy With Only A Fixed Combination Of Dorzolamide / Timolol Replaced.
    Pryzdryga, J, Schacknow, PN and the TRAVATAN START Study Group, 19th Congress of the Asia - Pacific Academy of Ophthalmology (APAO), Bangkok, Thailand, 1/29/2003

Lectures

  • Glaucoma Management in the Age of Generics 
    Ponce, Puerto Rico - 1/28/2011
  • Ocular Surface Disease Prevalence Among Glaucoma Patients 
    Epic Hotel, Miami, FL - 1/24/2011
  • A Comparison Of BAK-Free Glaucoma Therapies 
    Epic Hotel, Miami, FL - 1/24/2011

Other

  • Prescribing Generics. (Expert interview) 
    Schacknow, PN, Glaucoma Management, Vol.1 # 1, p. 13 (Vindico Medical Education)
    Thorofare, NJ - 1/15/2011
  • Topical CAIs are effective adjuncts to prostaglandins. (Telephone interview-article) 
    Schacknow, PN, Ocular Surgery News (by Erin Boyle)
    Thorofare, NJ - 1/15/2007
  • Balancing Power and Control in Glaucoma Therapy 
    Crandall, AS, Barneby, H, Cuneliffe, I, Miglior, S, Pryzdryga, J, Schacknow, PN, Teus, M, Ocular Surgery News, Europe/Asia-Pacific Edition
    1/1/2003

Press Mentions

  • Glaucoma 360 Reaches Milestones in Search of Glaucoma Cure
    Glaucoma 360 Reaches Milestones in Search of Glaucoma CureJanuary 29th, 2016

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: